Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease

per Abdul Razak, Albiruni Ryan, Li, Louise, Bryant, Andrew, Diaz-Padilla, Ivan
Publicat 2011

Estimation of expectedness: Predictive accuracy of standard therapy outcomes in randomized phase 3 studies in epithelial ovarian cancer

per Castonguay, Vincent, Wilson, Michelle K., Diaz‐Padilla, Ivan, Wang, Lisa, Oza, Amit M.
Publicat a Cancer (2014)

Safety and tolerance of enteral nutrition in COVID-19 critically ill patients, a retrospective study

per Osuna-Padilla, Iván, Rodríguez-Moguel, Nadia Carolina, Aguilar-Vargas, Adriana, Rodríguez-Llamazares, Sebastián
Publicat a Clin Nutr ESPEN (2021)

Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment

per Patrono, María Guadalupe, Minig, Lucas, Diaz-Padilla, Ivan, Romero, Nuria, Rodriguez Moreno, Juan Francisco, Garcia-Donas, Jesus
Publicat 2013

Fatal respiratory disease due to a homozygous intronic ABCA3 mutation: a case report

per Pachajoa, Harry, Ruiz-Botero, Felipe, Meza-Escobar, Luis Enrique, Villota-Delgado, Vania Alexandra, Ballesteros, Adriana, Padilla, Ivan, Duarte, Diana
Publicat a J Med Case Rep (2016)

Alcohol and tobacco consumption concordance and its correlates in older couples in Latin America

per Machado, Mayra Pires Alves, Opaleye, Davi Camara, Pereira, Tiago Veiga, Padilla, Ivan, Noto, Ana Regina, Prince, Martin, Ferri, Cleusa Pinheiro
Publicat a Geriatr Gerontol Int (2017)

A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours

per van Bussel, Mark T. J., Awada, Ahmad, de Jonge, Maja J. A., Mau-Sørensen, Morten, Nielsen, Dorte, Schöffski, Patrick, Verheul, Henk M. W., Sarholz, Barbara, Berghoff, Karin, El Bawab, Samer, Kuipers, Mirjam, Damstrup, Lars, Diaz-Padilla, Ivan, Schellens, Jan H. M.
Publicat a Br J Cancer (2020)

A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)

per Chiu, Joanne W., Hotte, Sebastien J., Kollmannsberger, Christian K., Renouf, Daniel J., Cescon, David W., Hedley, David, Chow, Sue, Moscow, Jeffrey, Chen, Zhuo, Perry, Meghan, Diaz-Padilla, Ivan, Tan, David, Hirte, Hal, McWhirter, Elaine, Chen, Helen, Siu, Lillian L., Bedard, Philippe L.
Publicat a Invest New Drugs (2015)

A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors

per Diaz-Padilla, Ivan, Hirte, Hal, Oza, Amit M., Clarke, Blaise A., Cohen, Brenda, Reedjik, Michael, Zhang, Tong, Kamel-Reid, Suzanne, Ivy, S. Percy, Hotte, Sebastien J., Razak, Albiruni A. R., Chen, Eric X., Brana, Irene, Wizemann, Monika, Wang, Lisa, Siu, Lillian L., Bedard, Philippe L.
Publicat 2013

A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)

per Mayer, Ingrid A., Prat, Aleix, Egle, Daniel, Blau, Sibel, Perez Fidalgo, J. Alejandro, Gnant, Michael, Fasching, Peter A., Colleoni, Marco, Wolff, Antonio C., Winer, Eric P., Singer, Christian F., Hurvitz, Sara, Estevez, Laura Garcia, van Dam, Peter A., Kümmel, Sherko, Mundhenke, Christoph, Holmes, Frankie, Babbar, Naveen, Charbonnier, Laure, Diaz-Padilla, Ivan, Vogl, Florian D., Sellami, Dalila, Arteaga, Carlos L.
Publicat a Clin Cancer Res (2019)

Ovarian Cancer

Publicat 2013